Serial Number | 79382926 |
Word Mark | APTEGRA |
Filing Date | Wednesday, October 11, 2023 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, September 10, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, September 10, 2024 |
Goods and Services | Biological research, clinical research in the field of pharmaceuticals, and medical research; scientific research; pharmaceutical research and development; preparation of reports relating to scientific research; research and development services in the field of antibodies; research and testing services in the fields of bacteriology and virology; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; Scientific research in the nature of conducting clinical trials for pharmaceutical products for others; consultancy relating to pharmaceutical research and development; preparation of scientific reports; conducting of scientific studies in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory services relating to scientific research; pharmaceutical product evaluation; genetic testing for scientific research purposes; research and development services in the field of gene therapy; product quality and safety testing services in the field of antibodies; product quality and safety testing services for vaccines and medicines; research and development in the field of cell therapies; product quality and safety testing services for gene or cell therapies |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, November 14, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Merck KGaA |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | DE |
Party Name | Merck KGaA |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | DE |
Event Date | Event Description |
Thursday, November 9, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Tuesday, November 14, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, December 21, 2023 | ASSIGNED TO EXAMINER |
Saturday, January 20, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, February 7, 2024 | REFUSAL PROCESSED BY MPU |
Wednesday, February 7, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, February 7, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Wednesday, February 7, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, February 7, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Wednesday, February 7, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, February 7, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Saturday, November 18, 2023 | APPLICATION FILING RECEIPT MAILED |
Friday, January 19, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, February 7, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, February 27, 2024 | REFUSAL PROCESSED BY IB |
Wednesday, June 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, June 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, June 5, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, August 2, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, August 2, 2024 | ASSIGNED TO EXAMINER |
Wednesday, August 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 10, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, September 10, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |